These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 4302345

  • 21. Bacteriology of tuberculosis with special reference to kanamycin and related drugs.
    Dye WE.
    Ann N Y Acad Sci; 1966 Jun 14; 132(2):901-4. PubMed ID: 4290030
    [No Abstract] [Full Text] [Related]

  • 22. [Tuberculostatic drugs of the second series. (Review of literature)].
    El'nik VI.
    Klin Med (Mosk); 1966 Dec 14; 44(12):19-24. PubMed ID: 4302920
    [No Abstract] [Full Text] [Related]

  • 23. Newer knowledge of chemotherapy in the treatment of tuberculosis of bones and joints.
    Friedman B, Kapur VN.
    Clin Orthop Relat Res; 1973 Dec 14; (97):5-15. PubMed ID: 4359522
    [No Abstract] [Full Text] [Related]

  • 24. [Experimental study of secondary tuberculostatic preparations in view of the resistance of mycobacteria to the primary drugs].
    Uvarova OA, Zemskova ZS, Stukalova BIa, Afanas'eva IuP.
    Farmakol Toksikol; 1967 Dec 14; 30(4):474-7. PubMed ID: 4877410
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S.
    Iryo; 1968 Oct 14; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Observations on antituberculous drug resistance among pulmonary tuberculosis patients at the national sanatoria in Kyushu district. 4. The primary and the secondary antituberculous agents].
    Yamaguchi S.
    Iryo; 1968 Oct 14; 22(10):1120-4. PubMed ID: 5710123
    [No Abstract] [Full Text] [Related]

  • 30. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M, Tarantino AB, Mac Dowell A, Costa JA, Cunha JM, Pantoja W.
    Rev Bras Med; 1967 Aug 14; 24(8):664-8. PubMed ID: 5603007
    [No Abstract] [Full Text] [Related]

  • 31. [Duration of the after-control of the tuberculous patients following the termination of the treatment].
    Neumann G.
    Wien Med Wochenschr; 1972 Dec 16; 122(51):764-8. PubMed ID: 4346497
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
    Mamolat AS, Bialik IB.
    Probl Tuberk; 1969 Dec 16; 47(6):23-8. PubMed ID: 4311969
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series].
    Rudoĭ NM, Utkin VV, Fedorova IE, Afanas'eva IuP.
    Antibiotiki; 1970 Apr 16; 15(4):355-7. PubMed ID: 4993044
    [No Abstract] [Full Text] [Related]

  • 38. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN, Barrera L.
    Medicina (B Aires); 2007 Apr 16; 67(3):231-7. PubMed ID: 17628909
    [Abstract] [Full Text] [Related]

  • 39. [Progress and problems in the diagnosis and therapy of urogenital tuberculosis].
    May P, König K.
    Internist (Berl); 1968 May 16; 9(5):195-207. PubMed ID: 4302540
    [No Abstract] [Full Text] [Related]

  • 40. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov 16; 46(11):423-8. PubMed ID: 4335256
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.